NovoCure Ltd · Brief

Next report

71 days

Jan 11 · before openest.Q4 FY26

Expected move

±4.9%implied · report alone

12.5113.79

straddle ±18.3%

spot 13.15exp Jan 15ATM strike 13ATM straddle 2.82IV 59%

Oct 30 closereport share · term structure

Expected move

8 reportsHistory

3 of 8≥ implied

Apr 24 '25±10.7%▲+4.39%×0.41

Jul 24 '25±10.1%▼−24.05%×2.37

Oct 30 '25±12.8%▼−4.90%×0.38

Jan 12 '26±11.9%▼−1.18%×0.10

Feb 26 '26±18.5%▼−8.27%×0.45

Q1 FY26±20.4%▲+27.49%×1.35

Q2 FY26±16.4%▲+28.39%×1.74

Q3 FY26±17.7%▼−7.48%×0.42

quarterimplied−30%0+30%realized×

Q3 FY26±17.7%▼−7.48%×0.42

Q2 FY26±16.4%▲+28.39%×1.74

Q1 FY26±20.4%▲+27.49%×1.35

Feb '26±18.5%▼−8.27%×0.45

Jan '26±11.9%▼−1.18%×0.10

Oct '25±12.8%▼−4.90%×0.38

2 older reports

Jul '25±10.1%▼−24.05%×2.37

Apr '25±10.7%▲+4.39%×0.41

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Jan 11 report · est.

—

NVCR report session

No linked exposure.

Oct 15impliedImplied move: ±13.8% into Oct 29 earnings (Oct 15 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.